| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Revenue | $4.35B | +0.9% |
| R&D Expense | $70.0M | +6.1% |
| SG&A Expense | $513.0M | -1.0% |
| Operating Income | $478.0M | +6.5% |
| Pre-tax Income | $189.0M | +36.0% |
| Income Tax | $27.0M | -42.6% |
| Net Income | $162.0M | +78.0% |
| EPS (Basic) | $2.20 | +74.6% |
| EPS (Diluted) | $2.14 |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $456.0M | +8.8% |
| Accounts Receivable | $550.0M | -6.5% |
| Inventory | $342.0M | +11.4% |
| Current Assets | $1.82B | +3.3% |
| Total Assets | $5.67B | +2.1% |
| Current Liabilities | $1.90B | +11.6% |
| Long-term Debt | $2.67B | -10.8% |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | $356.0M | +3.5% |
| Capital Expenditures | $117.0M | +34.5% |
| Investing Cash Flow | -$116.0M | +14.1% |
| Financing Cash Flow | -$253.0M | -88.8% |
| Free Cash Flow | $239.0M | -7.0% |
| +74.0% |
| Total Liabilities |
| $5.27B |
| -0.4% |
| Stockholders' Equity | $403.0M | +55.0% |